Table of Contents Author Guidelines Submit a Manuscript
Journal of Nanomaterials
Volume 2012, Article ID 673968, 13 pages
http://dx.doi.org/10.1155/2012/673968
Review Article

Nanomaterials for the Local and Targeted Delivery of Osteoarthritis Drugs

Department of Developmental Bioengineering, MIRA Institute for Biomedical Technology and Technical Medicine, Faculty of Science and Technology, University of Twente, 7522 NB Enschede, The Netherlands

Received 6 January 2012; Revised 17 February 2012; Accepted 20 February 2012

Academic Editor: Suprakas Sinha Ray

Copyright © 2012 Parthiban Chinnagounder Periyasamy et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. N. Gerwin, C. Hops, and A. Lucke, “Intraarticular drug delivery in osteoarthritis,” Advanced Drug Delivery Reviews, vol. 58, no. 2, pp. 226–242, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. M. Attur, J. Samuels, S. Krasnokutsky, and S. B. Abramson, “Targeting the synovial tissue for treating osteoarthritis (OA): where is the evidence?” Best Practice and Research, vol. 24, no. 1, pp. 71–79, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. R. J. Lories and F. P. Luyten, “The bone-cartilage unit in osteoarthritis,” Nature Reviews Rheumatology, vol. 7, no. 1, pp. 43–49, 2011. View at Publisher · View at Google Scholar
  4. S. Suri and D. A. Walsh, “Osteochondral alterations in osteoarthritis,” Bone. In press. View at Publisher · View at Google Scholar
  5. M. B. Goldring and S. R. Goldring, “Osteoarthritis,” Journal of Cellular Physiology, vol. 213, no. 3, pp. 626–634, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. J. W. J. Bijlsma, F. Berenbaum, and F. P. J. G. Lafeber, “Osteoarthritis: an update with relevance for clinical practice,” The Lancet, vol. 377, no. 9783, pp. 2115–2126, 2011. View at Publisher · View at Google Scholar
  7. L. Kock, C. C. van Donkelaar, and K. Ito, “Tissue engineering of functional articular cartilage: the current status,” Cell and Tissue Research, vol. 347, no. 3, pp. 613–627, 2012. View at Publisher · View at Google Scholar
  8. A. H. Reddi, J. Becerra, and J. A. Andrades, “Nanomaterials and hydrogel scaffolds for articular cartilage regeneration,” Tissue Engineering—Part B, vol. 17, no. 5, pp. 301–305, 2011. View at Publisher · View at Google Scholar
  9. J. Bertrand, C. Cromme, D. Umlauf, S. Frank, and T. Pap, “Molecular mechanisms of cartilage remodelling in osteoarthritis,” International Journal of Biochemistry and Cell Biology, vol. 42, no. 10, pp. 1594–1601, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Kapoor, J. Martel-Pelletier, D. Lajeunesse, J. P. Pelletier, and H. Fahmi, “Role of proinflammatory cytokines in the pathophysiology of osteoarthritis,” Nature Reviews Rheumatology, vol. 7, no. 1, pp. 33–42, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. M. B. Mueller and R. S. Tuan, “Anabolic/Catabolic balance in pathogenesis of osteoarthritis: identifying molecular targets,” PM & R, vol. 3, no. 6, supplement 1, pp. S3–S11, 2011. View at Google Scholar
  12. T. P. Andriacchi and A. Mündermann, “The role of ambulatory mechanics in the initiation and progression of knee osteoarthritis,” Current Opinion in Rheumatology, vol. 18, no. 5, pp. 514–518, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. M. J. Alcaraz, J. Megías, I. García-Arnandis, V. Clérigues, and M. I. Guillén, “New molecular targets for the treatment of osteoarthritis,” Biochemical Pharmacology, vol. 80, no. 1, pp. 13–21, 2010. View at Publisher · View at Google Scholar
  14. C. Beyer and G. Schett, “Novel targets in bone and cartilage,” Best Practice and Research, vol. 24, no. 4, pp. 489–496, 2010. View at Publisher · View at Google Scholar
  15. K. B. Marcu, M. Otero, E. Olivotto, R. M. Borzi, and M. B. Goldring, “NF-κB signaling: multiple angles to target OA,” Current Drug Targets, vol. 11, no. 5, pp. 599–613, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. L. A. J. O'Neill, “Targeting signal transduction as a strategy to treat inflammatory diseases,” Nature Reviews Drug Discovery, vol. 5, no. 7, pp. 549–563, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. M. Talekar, J. Kendall, W. Denny, and S. Garg, “Targeting of nanoparticles in cancer: drug delivery and diagnostics,” Anti-Cancer Drugs, vol. 22, no. 10, pp. 949–962, 2011. View at Publisher · View at Google Scholar
  18. X. Chi, D. Huang, Z. Zhao, Z. Zhou, Z. Yin, and J. Gao, “Nanoprobes for in vitro diagnostics of cancer and infectious diseases,” Biomaterials, vol. 33, no. 1, pp. 189–206, 2012. View at Publisher · View at Google Scholar
  19. C. Shanholtz, “Acute life-threatening toxicity of cancer treatment,” Critical Care Clinics, vol. 17, no. 3, pp. 483–502, 2001. View at Publisher · View at Google Scholar · View at Scopus
  20. T. Lammers, F. Kiessling, W. E. Hennink, and G. Storm, “Drug targeting to tumors: principles, pitfalls and (pre-) clinical progress,” Journal of Controlled Release. In press. View at Publisher · View at Google Scholar
  21. K. Kataoka, A. Harada, and Y. Nagasaki, “Block copolymer micelles for drug delivery: design, characterization and biological significance,” Advanced Drug Delivery Reviews, vol. 47, no. 1, pp. 113–131, 2001. View at Publisher · View at Google Scholar · View at Scopus
  22. M. F. Francis, M. Cristea, and F. M. Winnik, “Polymeric micelles for oral drug delivery: why and how,” Pure and Applied Chemistry, vol. 76, no. 7-8, pp. 1321–1335, 2004. View at Google Scholar · View at Scopus
  23. M. Yokoyama, G. S. Kwon, T. Okano, Y. Sakurai, T. Seto, and K. Kataoka, “Preparation of micelle-forming polymer-drug conjugates,” Bioconjugate Chemistry, vol. 3, no. 4, pp. 295–301, 1992. View at Google Scholar · View at Scopus
  24. U. Kedar, P. Phutane, S. Shidhaye, and V. Kadam, “Advances in polymeric micelles for drug delivery and tumor targeting,” Nanomedicine, vol. 6, no. 6, pp. 714–729, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. A. Mahmud, X. B. Xiong, H. M. Aliabadi, and A. Lavasanifar, “Polymeric micelles for drug targeting,” Journal of Drug Targeting, vol. 15, no. 9, pp. 553–584, 2007. View at Publisher · View at Google Scholar · View at Scopus
  26. C. Oerlemans, W. Bult, M. Bos, G. Storm, J. F. W. Nijsen, and W. E. Hennink, “Polymeric micelles in anticancer therapy: targeting, imaging and triggered release,” Pharmaceutical Research, pp. 1–21, 2010. View at Publisher · View at Google Scholar · View at Scopus
  27. K. Osada, R. J. Christie, and K. Kataoka, “Polymeric micelles from poly(ethylene glycol)-poly(amino acid) block copolymer for drug and gene delivery,” Journal of the Royal Society Interface, vol. 6, no. 3, pp. S325–S339, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. K. Kataoka, G. S. Kwon, M. Yokoyama, T. Okano, and Y. Sakurai, “Block copolymer micelles as vehicles for drug delivery,” Journal of Controlled Release, vol. 24, no. 1–3, pp. 119–132, 1993. View at Publisher · View at Google Scholar · View at Scopus
  29. K. Miyata, R. J. Christie, and K. Kataoka, “Polymeric micelles for nano-scale drug delivery,” Reactive and Functional Polymers, vol. 71, no. 3, pp. 227–234, 2011. View at Publisher · View at Google Scholar · View at Scopus
  30. H. Chen, C. Khemtong, X. Yang, X. Chang, and J. Gao, “Nanonization strategies for poorly water-soluble drugs,” Drug Discovery Today, vol. 16, no. 7-8, pp. 354–360, 2011. View at Publisher · View at Google Scholar · View at Scopus
  31. D. A. Rothenfluh, H. Bermudez, C. P. O'Neil, and J. A. Hubbell, “Biofunctional polymer nanoparticles for intra-articular targeting and retention in cartilage,” Nature Materials, vol. 7, no. 3, pp. 248–254, 2008. View at Publisher · View at Google Scholar · View at Scopus
  32. I. I. Singer, D. W. Kawka, E. K. Bayne et al., “VDIPEN, a metalloproteinase-generated neoepitope, is induced and immunolocalized in articular cartilage during inflammatory arthritis,” The Journal of Clinical Investigation, vol. 95, no. 5, pp. 2178–2186, 1995. View at Google Scholar · View at Scopus
  33. R. A. Schwendener, “Liposomes in biology and medicine,” Advances in Experimental Medicine and Biology, vol. 620, pp. 117–128, 2007. View at Publisher · View at Google Scholar · View at Scopus
  34. V. P. Torchilin, “Recent advances with liposomes as pharmaceutical carriers,” Nature Reviews Drug Discovery, vol. 4, no. 2, pp. 145–160, 2005. View at Publisher · View at Google Scholar · View at Scopus
  35. F. Yang, C. Jin, Y. Jiang et al., “Liposome based delivery systems in pancreatic cancer treatment: from bench to bedside,” Cancer Treatment Reviews, vol. 37, no. 8, pp. 633–642, 2011. View at Publisher · View at Google Scholar
  36. M. Slingerland, H.-J. Guchelaar, and H. Gelderblom, “Liposomal drug formulations in cancer therapy: 15 years along the road,” Drug Discovery Today, vol. 17, no. 3-4, pp. 160–166, 2012. View at Publisher · View at Google Scholar
  37. M. P. Czech, M. Aouadi, and G. J. Tesz, “RNAi-based therapeutic strategies for metabolic disease,” Nature Reviews Endocrinology, vol. 7, no. 8, pp. 473–484, 2011. View at Publisher · View at Google Scholar
  38. R. B. Campbell, B. Ying, G. M. Kuesters, and R. Hemphill, “Fighting cancer: from the bench to bedside using second generation cationic liposomal therapeutics,” Journal of Pharmaceutical Sciences, vol. 98, no. 2, pp. 411–429, 2009. View at Publisher · View at Google Scholar · View at Scopus
  39. A. Gabizon, H. Shmeeda, A. T. Horowitz, and S. Zalipsky, “Tumor cell targeting of liposome-entrapped drugs with phospholipid-anchored folic acid-PEG conjugates,” Advanced Drug Delivery Reviews, vol. 56, no. 8, pp. 1177–1192, 2004. View at Publisher · View at Google Scholar · View at Scopus
  40. Y. Lu and P. S. Low, “Folate-mediated delivery of macromolecular anticancer therapeutic agents,” Advanced Drug Delivery Reviews, vol. 54, no. 5, pp. 675–693, 2002. View at Publisher · View at Google Scholar · View at Scopus
  41. H. Li and Z. M. Qian, “Transferrin/transferrin receptor-mediated drug delivery,” Medicinal Research Reviews, vol. 22, no. 3, pp. 225–250, 2002. View at Publisher · View at Google Scholar
  42. G. Zhai, J. Wu, B. Yu, C. Guo, X. Yang, and R. J. Lee, “A transferrin receptor-targeted liposomal formulation for docetaxel,” Journal of Nanoscience and Nanotechnology, vol. 10, no. 8, pp. 5129–5136, 2010. View at Publisher · View at Google Scholar
  43. R. Srinivasan, R. E. Marchant, and A. S. Gupta, “In vitro and in vivo platelet targeting by cyclic RGD-modified liposomes,” Journal of Biomedical Materials Research—Part A, vol. 93, no. 3, pp. 1004–1015, 2010. View at Publisher · View at Google Scholar · View at Scopus
  44. H. Fattahi, S. Laurent, F. Liu, N. Arsalani, L. V. Elst, and R. N. Muller, “Magnetoliposomes as multimodal contrast agents for molecular imaging and cancer nanotheragnostics,” Nanomedicine, vol. 6, no. 3, pp. 529–544, 2011. View at Publisher · View at Google Scholar
  45. W. J. M. Mulder, G. J. Strijkers, G. A. F. van Tilborg, A. W. Griffioen, and K. Nicolay, “Lipid-based nanoparticles for contrast-enhanced MRI and molecular imaging,” NMR in Biomedicine, vol. 19, no. 1, pp. 142–164, 2006. View at Publisher · View at Google Scholar · View at Scopus
  46. V. P. Torchilin, T. S. Levchenko, K. R. Whiteman et al., “Amphiphilic poly-N-vinylpyrrolidones: synthesis, properties and liposome surface modification,” Biomaterials, vol. 22, no. 22, pp. 3035–3044, 2001. View at Publisher · View at Google Scholar · View at Scopus
  47. I. A. Yamskov, A. N. Kuskov, K. K. Babievsky et al., “Novel liposomal forms of antifungal antibiotics modified by amphiphilic polymers,” Applied Biochemistry and Microbiology, vol. 44, no. 6, pp. 624–628, 2008. View at Publisher · View at Google Scholar · View at Scopus
  48. K. Nakano, Y. Tozuka, and H. Takeuchi, “Effect of surface properties of liposomes coated with a modified polyvinyl alcohol (PVA-R) on the interaction with macrophage cells,” International Journal of Pharmaceutics, vol. 354, no. 1-2, pp. 174–179, 2008. View at Publisher · View at Google Scholar · View at Scopus
  49. A. Ishihara, M. Yamauchi, H. Kusano et al., “Preparation and properties of branched oligoglycerol modifiers for stabilization of liposomes,” International Journal of Pharmaceutics, vol. 391, no. 1-2, pp. 237–243, 2010. View at Publisher · View at Google Scholar · View at Scopus
  50. I. Elron-Gross, Y. Glucksam, and R. Margalit, “Liposomal dexamethasone-diclofenac combinations for local osteoarthritis treatment,” International Journal of Pharmaceutics, vol. 376, no. 1-2, pp. 84–91, 2009. View at Publisher · View at Google Scholar · View at Scopus
  51. R. Goldberg, A. Schroeder, Y. Barenholz, and J. Klein, “Interactions between adsorbed hydrogenated soy phosphatidylcholine (HSPC) vesicles at physiologically high pressures and salt concentrations,” Biophysical Journal, vol. 100, no. 10, pp. 2403–2411, 2011. View at Publisher · View at Google Scholar
  52. R. Goldberg, A. Schroeder, G. Silbert, K. Turjeman, Y. Barenholz, and J. Klein, “Boundary lubricants with exceptionally low friction coefficients based on 2D close-packed phosphatidylcholine liposomes,” Advanced Materials, vol. 23, no. 31, pp. 3517–3521, 2011. View at Publisher · View at Google Scholar
  53. M. Trie, C. Guillen, D. M. Vaughan et al., “Liposomes as possible carriers for lactoferrin in the local treatment of inflammatory diseases,” Experimental Biology and Medicine, vol. 226, no. 6, pp. 559–564, 2001. View at Google Scholar · View at Scopus
  54. V. P. Torchilin, A. N. Lukyanov, Z. Gao, and B. Papahadjopoulos-Sternberg, “Immunomicelles: targeted pharmaceutical carriers for poorly soluble drugs,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 10, pp. 6039–6044, 2003. View at Publisher · View at Google Scholar · View at Scopus
  55. J. Vega, S. Ke, Z. Fan, S. Wallace, C. Charsangavej, and C. Li, “Targeting doxorubicin to epidermal growth factor receptors by site-specific conjugation of C225 to poly(L-glutamic acid) through a polyethylene glycol spacer,” Pharmaceutical Research, vol. 20, no. 5, pp. 826–832, 2003. View at Publisher · View at Google Scholar · View at Scopus
  56. M. C. Palanca-Wessels, A. J. Convertine, R. Cutler-Strom et al., “Anti-CD22 antibody targeting of pH-responsive micelles enhances small interfering RNA delivery and gene silencing in lymphoma cells,” Molecular Therapy, vol. 19, no. 8, pp. 1529–1537, 2011. View at Publisher · View at Google Scholar
  57. N. Nasongkla, X. Shuai, H. Ai et al., “cRGD-functionalized polymer micelles for targeted doxorubicin delivery,” Angewandte Chemie—International Edition, vol. 43, no. 46, pp. 6323–6327, 2004. View at Publisher · View at Google Scholar · View at Scopus
  58. O. M. Y. Koo, I. Rubinstein, and H. Önyüksel, “Actively targeted low-dose camptothecin as a safe, long-acting, disease-modifying nanomedicine for rheumatoid arthritis,” Pharmaceutical Research, vol. 28, no. 4, pp. 776–787, 2011. View at Publisher · View at Google Scholar · View at Scopus
  59. K. Shao, R. Huang, J. Li et al., “Angiopep-2 modified PE-PEG based polymeric micelles for amphotericin B delivery targeted to the brain,” Journal of Controlled Release, vol. 147, no. 1, pp. 118–126, 2010. View at Publisher · View at Google Scholar · View at Scopus
  60. H. S. Yoo and T. G. Park, “Folate receptor targeted biodegradable polymeric doxorubicin micelles,” Journal of Controlled Release, vol. 96, no. 2, pp. 273–283, 2004. View at Publisher · View at Google Scholar · View at Scopus
  61. E. K. Park, S. B. Lee, and Y. M. Lee, “Preparation and characterization of methoxy poly(ethylene glycol)/poly(ε-caprolactone) amphiphilic block copolymeric nanospheres for tumor-specific folate-mediated targeting of anticancer drugs,” Biomaterials, vol. 26, no. 9, pp. 1053–1061, 2005. View at Publisher · View at Google Scholar · View at Scopus
  62. X. Han, J. Liu, M. Liu et al., “9-NC-loaded folate-conjugated polymer micelles as tumor targeted drug delivery system: preparation and evaluation in vitro,” International Journal of Pharmaceutics, vol. 372, no. 1-2, pp. 125–131, 2009. View at Publisher · View at Google Scholar · View at Scopus
  63. Y. C. Wang, X. Q. Liu, T. M. Sun, M. H. Xiong, and J. Wang, “Functionalized micelles from block copolymer of polyphosphoester and poly(e{open}-caprolactone) for receptor-mediated drug delivery,” Journal of Controlled Release, vol. 128, no. 1, pp. 32–40, 2008. View at Publisher · View at Google Scholar · View at Scopus
  64. G. R. Newkome and C. D. Shreiner, “Poly(amidoamine), polypropylenimine, and related dendrimers and dendrons possessing different 1 → 2 branching motifs: an overview of the divergent procedures,” Polymer, vol. 49, no. 1, pp. 1–173, 2008. View at Publisher · View at Google Scholar · View at Scopus
  65. C. J. Hawker and J. M. J. Fréchet, “Preparation of polymers with controlled molecular architecture. A new convergent approach to dendritic macromolecules,” Journal of the American Chemical Society, vol. 112, no. 21, pp. 7638–7647, 1990. View at Google Scholar · View at Scopus
  66. M. J. Joralemon, R. K. O'Reilly, J. B. Matson, A. K. Nugent, C. J. Hawker, and K. L. Wooley, “Dendrimers clicked together divergently,” Macromolecules, vol. 38, no. 13, pp. 5436–5443, 2005. View at Publisher · View at Google Scholar · View at Scopus
  67. K. L. Killops, L. M. Campos, and C. J. Hawker, “Robust, efficient, and orthogonal synthesis of dendrimers via thiol-ene “click” chemistry,” Journal of the American Chemical Society, vol. 130, no. 15, pp. 5062–5064, 2008. View at Publisher · View at Google Scholar · View at Scopus
  68. L. Brauge, G. Magro, A. M. Caminade, and J. P. Majoral, “First divergent strategy using two AB2 unprotected monomers for the rapid synthesis of dendrimers,” Journal of the American Chemical Society, vol. 123, no. 27, pp. 6698–6699, 2001. View at Publisher · View at Google Scholar · View at Scopus
  69. M. Slany, A. M. Caminade, and J. P. Majoral, “Specific functionalization on the surface of dendrimers,” Tetrahedron Letters, vol. 37, no. 50, pp. 9053–9056, 1996. View at Publisher · View at Google Scholar · View at Scopus
  70. P. Wu, M. Malkoch, J. N. Hunt et al., “Multivalent, bifunctional dendrimers prepared by click chemistry,” Chemical Communications, no. 46, pp. 5775–5777, 2005. View at Publisher · View at Google Scholar · View at Scopus
  71. A. K. Patri, J. F. Kukowska-Latallo, and J. R. Baker, “Targeted drug delivery with dendrimers: comparison of the release kinetics of covalently conjugated drug and non-covalent drug inclusion complex,” Advanced Drug Delivery Reviews, vol. 57, no. 15, pp. 2203–2214, 2005. View at Publisher · View at Google Scholar · View at Scopus
  72. M. Liu, K. Kono, and J. M. J. Fréchet, “Water-soluble dendritic unimolecular micelles: their potential as drug delivery agents,” Journal of Controlled Release, vol. 65, no. 1-2, pp. 121–131, 2000. View at Publisher · View at Google Scholar · View at Scopus
  73. C. Kojima, K. Kono, K. Maruyama, and T. Takagishi, “Synthesis of polyamidoamine dendrimers having poly(ethylene glycol) grafts and their ability to encapsulate anticancer drugs,” Bioconjugate Chemistry, vol. 11, no. 6, pp. 910–917, 2000. View at Publisher · View at Google Scholar · View at Scopus
  74. S. Svenson, “Dendrimers as versatile platform in drug delivery applications,” European Journal of Pharmaceutics and Biopharmaceutics, vol. 71, no. 3, pp. 445–462, 2009. View at Publisher · View at Google Scholar · View at Scopus
  75. J. Lim, A. Chouai, S. T. Lo, W. Liu, X. Sun, and E. E. Simanek, “Design, synthesis, characterization, and biological evaluation of triazine dendrimers bearing paclitaxel using ester and ester/disulfide linkages,” Bioconjugate Chemistry, vol. 20, no. 11, pp. 2154–2161, 2009. View at Publisher · View at Google Scholar · View at Scopus
  76. A. Quintana, E. Raczka, L. Piehler et al., “Design and function of a dendrimer-based therapeutic nanodevice targeted to tumor cells through the folate receptor,” Pharmaceutical Research, vol. 19, no. 9, pp. 1310–1316, 2002. View at Publisher · View at Google Scholar · View at Scopus
  77. T. Dutta, H. B. Agashe, M. Garg, P. Balasubramanium, M. Kabra, and N. K. Jain, “Poly (propyleneimine) dendrimer based nanocontainers for targeting of efavirenz to human monocytes/macrophages in vitro,” Journal of Drug Targeting, vol. 15, no. 1, pp. 89–98, 2007. View at Publisher · View at Google Scholar · View at Scopus
  78. W. Yang, Y. Cheng, T. Xu, X. Wang, and L. P. Wen, “Targeting cancer cells with biotin-dendrimer conjugates,” European Journal of Medicinal Chemistry, vol. 44, no. 2, pp. 862–868, 2009. View at Publisher · View at Google Scholar · View at Scopus
  79. B. H. Zinselmeyer, S. P. Mackay, A. G. Schatzlein, and I. F. Uchegbu, “The lower-generation polypropylenimine dendrimers are effective gene-transfer agents,” Pharmaceutical Research, vol. 19, no. 7, pp. 960–967, 2002. View at Publisher · View at Google Scholar · View at Scopus
  80. F. Tack, A. Bakker, S. Maes et al., “Modified poly(propylene imine) dendrimers as effective transfection agents for catalytic DNA enzymes (DNAzymes),” Journal of Drug Targeting, vol. 14, no. 2, pp. 69–86, 2006. View at Publisher · View at Google Scholar · View at Scopus
  81. D. Luo, K. Haverstick, N. Belcheva, E. Han, and W. M. Saltzman, “Poly(ethylene glycol)-conjugated PAMAM dendrimer for biocompatible, high-efficiency DNA delivery,” Macromolecules, vol. 35, no. 9, pp. 3456–3462, 2002. View at Publisher · View at Google Scholar · View at Scopus
  82. C. S. Winalski, S. Shortkroff, E. Schneider, H. Yoshioka, R. V. Mulkern, and G. M. Rosen, “Targeted dendrimer-based contrast agents for articular cartilage assessment by MR imaging,” Osteoarthritis and Cartilage, vol. 16, no. 7, pp. 815–822, 2008. View at Publisher · View at Google Scholar · View at Scopus
  83. M. Hayder, M. Poupot, M. Baron et al., “A phosphorus-based dendrimer targets inflammation and osteoclastogenesis in experimental arthritis,” Science Translational Medicine, vol. 3, no. 81, Article ID 81ra35, 2011. View at Publisher · View at Google Scholar
  84. S. Svenson and D. A. Tomalia, “Dendrimers in biomedical applications—reflections on the field,” Advanced Drug Delivery Reviews, vol. 57, no. 15, pp. 2106–2129, 2005. View at Publisher · View at Google Scholar · View at Scopus
  85. S. Acharya and S. K. Sahoo, “PLGA nanoparticles containing various anticancer agents and tumour delivery by EPR effect,” Advanced Drug Delivery Reviews, vol. 63, no. 3, pp. 170–183, 2011. View at Publisher · View at Google Scholar · View at Scopus
  86. J. M. Chan, L. Zhang, R. Tong et al., “Spatiotemporal controlled delivery of nanoparticles to injured vasculature,” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 5, pp. 2213–2218, 2010. View at Publisher · View at Google Scholar · View at Scopus
  87. K. S. Soppimath, T. M. Aminabhavi, A. R. Kulkarni, and W. E. Rudzinski, “Biodegradable polymeric nanoparticles as drug delivery devices,” Journal of Controlled Release, vol. 70, no. 1-2, pp. 1–20, 2001. View at Publisher · View at Google Scholar · View at Scopus
  88. M. F. Zambaux, F. Bonneaux, R. Gref, E. Dellacherie, and C. Vigneron, “Preparation and characterization of protein C-loaded PLA nanoparticles,” Journal of Controlled Release, vol. 60, no. 2-3, pp. 179–188, 1999. View at Publisher · View at Google Scholar · View at Scopus
  89. D. E. Owens and N. A. Peppas, “Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles,” International Journal of Pharmaceutics, vol. 307, no. 1, pp. 93–102, 2006. View at Publisher · View at Google Scholar · View at Scopus
  90. S. Y. Kim and Y. M. Lee, “Taxol-loaded block copolymer nanospheres composed of methoxy poly(ethylene glycol) and poly(ε-caprolactone) as novel anticancer drug carriers,” Biomaterials, vol. 22, no. 13, pp. 1697–1704, 2001. View at Publisher · View at Google Scholar · View at Scopus
  91. S. Prabha and V. Labhasetwar, “Nanoparticle-mediated wild-type p53 gene delivery results in sustained antiproliferative activity in breast cancer cells,” Molecular Pharmaceutics, vol. 1, no. 3, pp. 211–219, 2004. View at Google Scholar · View at Scopus
  92. S. K. Nune, P. Gunda, P. K. Thallapally, Y. Y. Lin, M. L. Forrest, and C. J. Berkland, “Nanoparticles for biomedical imaging,” Expert Opinion on Drug Delivery, vol. 6, no. 11, pp. 1175–1194, 2009. View at Google Scholar · View at Scopus
  93. A. Mahapatro and D. K. Singh, “Biodegradable nanoparticles are excellent vehicle for site directed in-vivo delivery of drugs and vaccines,” Journal of Nanobiotechnology, vol. 9, article 55, 2011. View at Publisher · View at Google Scholar
  94. Y. Liu, H. Miyoshi, and M. Nakamura, “Nanomedicine for drug delivery and imaging: a promising avenue for cancer therapy and diagnosis using targeted functional nanoparticles,” International Journal of Cancer, vol. 120, no. 12, pp. 2527–2537, 2007. View at Publisher · View at Google Scholar · View at Scopus
  95. D. A. Willoughby, A. R. Moore, and P. R. Colville-Nash, “COX-1, COX-2, and COX-3 and the future treatment of chronic inflammatory disease,” The Lancet, vol. 355, no. 9204, pp. 646–648, 2000. View at Google Scholar · View at Scopus
  96. E. M. Antman, J. S. Bennett, A. Daugherty, C. Furberg, H. Roberts, and K. A. Taubert, “Use of nonsteroidal antiinflammatory drugs: an update for clinicians: a scientific statement from the American Heart Association,” Circulation, vol. 115, no. 12, pp. 1634–1642, 2007. View at Publisher · View at Google Scholar · View at Scopus
  97. A. Dray and S. J. Read, “Arthritis and pain. Future targets to control osteoarthritis pain,” Arthritis Research and Therapy, vol. 9, no. 3, article 212, 2007. View at Publisher · View at Google Scholar · View at Scopus
  98. G. Herrero-Beaumont, J. A. Román Ivorra, M. D. C. Trabado et al., “Glucosamine sulfate in the treatment of knee osteoarthritis symptoms: a randomized, double-blind, placebo-controlled study using acetaminophen as a side comparator,” Arthritis and Rheumatism, vol. 56, no. 2, pp. 555–567, 2007. View at Publisher · View at Google Scholar
  99. L. M. Wildi, J.-P. Raynauld, J. Martel-Pelletier et al., “Chondroitin sulphate reduces both cartilage volume loss and bone marrow lesions in knee osteoarthritis patients starting as early as 6 months after initiation of therapy: a randomised, double-blind, placebo-controlled pilot study using MRI,” Annals of the Rheumatic Diseases, vol. 70, no. 6, pp. 982–989, 2011. View at Publisher · View at Google Scholar
  100. K. Pavelka, T. Trč, K. Karpaš et al., “The efficacy and safety of diacerein in the treatment of painful osteoarthritis of the knee: a randomized, multicenter, double-blind, placebo-controlled study with primary end points at two months after the end of a three-month treatment period,” Arthritis and Rheumatism, vol. 56, no. 12, pp. 4055–4064, 2007. View at Publisher · View at Google Scholar
  101. C. Böhm, S. Hayer, A. Kilian et al., “The α-isoform of p38 MAPK specifically regulates arthritic bone loss,” Journal of Immunology, vol. 183, no. 9, pp. 5938–5947, 2009. View at Publisher · View at Google Scholar · View at Scopus
  102. K. K. Brown, S. A. Heitmeyer, E. B. Hookfin et al., “P38 MAP kinase inhibitors as potential therapeutics for the treatment of joint degeneration and pain associated with osteoarthritis,” Journal of Inflammation, vol. 5, article 22, 2008. View at Publisher · View at Google Scholar · View at Scopus
  103. M. R. Lee and C. Dominguez, “MAP kinase p38 inhibitors: clinical results and an intimate look at their interactions with p38α protein,” Current Medicinal Chemistry, vol. 12, no. 25, pp. 2979–2994, 2005. View at Publisher · View at Google Scholar · View at Scopus
  104. S. H. R. Edwards, “Intra-articular drug delivery: the challenge to extend drug residence time within the joint,” Veterinary Journal, vol. 190, no. 1, pp. 15–21, 2011. View at Publisher · View at Google Scholar
  105. T. Nakasa, Y. Nagata, K. Yamasaki, and M. Ochi, “A mini-review: microRNA in arthritis,” Physiological Genomics, vol. 43, no. 10, pp. 566–570, 2011. View at Publisher · View at Google Scholar
  106. A. L. Clutterbuck, K. E. Asplin, P. Harris, D. Allaway, and A. Mobasheri, “Targeting matrix metalloproteinases in inflammatory conditions,” Current Drug Targets, vol. 10, no. 12, pp. 1245–1254, 2009. View at Publisher · View at Google Scholar · View at Scopus
  107. W. D. Comper, Cartilage: Molecular Aspects, CRC Press, 1991.
  108. P. A. Torzilli, J. M. Arduino, J. D. Gregory, and M. Bansal, “Effect of proteoglycan removal on solute mobility in articular cartilage,” Journal of Biomechanics, vol. 30, no. 9, pp. 895–902, 1997. View at Publisher · View at Google Scholar · View at Scopus
  109. T. Ushiyama, T. Chano, K. Inoue, and Y. Matsusue, “Cytokine production in the infrapatellar fat pad: another source of cytokines in knee synovial fluids,” Annals of the Rheumatic Diseases, vol. 62, no. 2, pp. 108–112, 2003. View at Publisher · View at Google Scholar · View at Scopus
  110. J. Sellam and F. Berenbaum, “The role of synovitis in pathophysiology and clinical symptoms of osteoarthritis,” Nature Reviews Rheumatology, vol. 6, no. 11, pp. 625–635, 2010. View at Publisher · View at Google Scholar · View at Scopus